Quattro Financial Advisors »

Akero Therapeutics shares owned by Quattro Financial Advisors

Quarter-by-quarter ownership of Akero Therapeutics (AKRO) shares owned by Quattro Financial Advisors from 13F filings

Historical chart of Quattro Financial Advisors investment in Akero Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Akero Therapeutics held by Quattro Financial Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Akero Therapeutics by Quattro Financial Advisors

Quarter filed Position value Share count Share price at filing
2024-03-31 $253k 10k 25.26
2023-12-31 $234k 23 10152.17

More positions owned by Quattro Financial Advisors

Microsoft Corporation (MSFT)
Invesco Exchange Traded Fd T S&p 500 Top 50 (XLG)
Ishares Bitcoin Tr SHS
Amazon (AMZN)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Ishares Tr Core Us Aggbd Et (AGG)
salesforce (CRM)
Emerson Electric (EMR)
Invesco Exchange Traded Fd T S&p500 Eql Wgt (RSP)
Alphabet Cap Stk Cl A (GOOGL)
Moderna (MRNA)
Vanguard Scottsdale Fds Shrt Trm Corp Bd (VCSH)
JPMorgan Chase & Co. (JPM)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Core Total Usd (IUSB)

View all positions for Quattro Financial Advisors

Top funds holding Akero Therapeutics

Henderson Group
T. Rowe Price Associates
Vanguard Group
Wellington Management Company
Baker Bros. Advisors
Yiheng Capital
Boxer Capital
Alliancebernstein
Redmile Group
Perceptive Advisors
Logos Global Management
Point72 Asset Management
Citadel Advisors
Goldman Sachs Group
Holocene Advisors

View all funds holding Akero Therapeutics